QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE
申请人:Suzuki Masaki
公开号:US20140315886A1
公开(公告)日:2014-10-23
Methods of treating disorders using compounds (I) that modulate stri-atal-enriched tyrosine phosphatase (STEP) are described herein. Exemplary disorders include schizophrenia and cognitive deficit. Formula (I).
Chemoselective nitro reduction and hydroamination using a single iron catalyst
作者:Kailong Zhu、Michael P. Shaver、Stephen P. Thomas
DOI:10.1039/c5sc04471e
日期:——
The reduction and reductive addition (formal hydroamination) of functionalised nitroarenes is reported using a simple and bench-stable iron(III) catalyst and silane. The reduction is chemoselective for nitro groups over an array of reactive functionalities (ketone, ester, amide, nitrile, sulfonyl and aryl halide). The high activity of this earth-abundant metal catalyst also facilitates a follow-on